Tenapanor safety study for teens with constipation-predominant IBS
Treatments studied
Part of Digestive system clinical trials.
This trial checks the safety of tenapanor in children and teens (ages 6 to under 18) with IBS-C. It is only for people who finished a previous related study and agreed to continue follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and under 18 years old when you enroll
- You must have finished the earlier (parent) study right before this one and followed the study plan well
- If you could become pregnant, you must have a negative pregnancy test at the end of the parent study and use birth control (or not have sex)
- You need to be able to move around on your own (ambulatory)
- A parent/guardian must give permission, and you (the child) must be willing to follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called tenapanor for people with chronic idiopathic constipation (constipation with no clear cause). It aims to see if the drug can safely improve bowel movements in adults.
This study tests whether a medication called tenapanor can help relieve constipation in people with Parkinson's disease. If you have Parkinson's and have been struggling with constipation for at least 6 months, this trial may offer a new option to improve bowel regularity.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
This trial tests whether a new medicine, IN-114199, is safe in healthy adults. It also looks at how the body processes the drug and how food affects it.
This trial tests a new drug called CMTS4520 for people with long-term constipation. It aims to see if the drug can help you have more bowel movements without needing laxatives or other help. The study lasts for several months and includes regular check-ups.
This trial tests a new oral medication, icotrokinra, for people with moderately to severely active ulcerative colitis. It may be an option if you have not responded well enough to standard treatments or newer advanced therapies.
Hear when a new Irritable Bowel Syndrome With Constipation (IBS-C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.